joimax entered into a distribution agreement with Transmedic Group to represent joimax spinal products in Singapore, Hong Kong, Philippines and Indonesia.
Specifically, the partnership will offer joimax endoscopic minimally invasive spinal surgical devices in these markets.
“joimax® is very much looking forward to working with Transmedic Group,” says joimax® Founder and CEO Wolfgang Ries. “With the rising popularity of endoscopic approaches in the management of spinal diseases, we’re able to deliver the highest standard of patient care, strengthen our sales activities, and enter into another important partnership across APAC.”
Teo Kee Meng, Managing Director of Transmedic Group commented, “We’re very pleased to partner with joimax®. With their technological advancements and use of new spinal access corridors, a major prevention of spinal structure collateral damage is assured, allowing for significantly reduced complications and improved postoperative recovery times."